Magda Michna on leadership
From OIS Podcast Ep #367: A Fast, Fun Future, with Warren Foust and Magda Michna, PhD, Staar Surgical · · OIS: Ophthalmology Innovation Source
“One of the things I love about joining STAAR Surgical was the ability to start a new organization and build synergies across multiple groups. I am passionate about developing teams and leaders, and I want to grow the next group of leaders in regulatory, clinical, and medical affairs.”
On , Magda Michna, Chief Development Officer and Chief Clinical, Regulatory & Medical Affairs Officer at STAAR SURGICAL CO, spoke about leadership during OIS Podcast Ep #367: A Fast, Fun Future, with Warren Foust and Magda Michna, PhD, Staar Surgical on OIS: Ophthalmology Innovation Source.
About Magda Michna
In a September 2023 podcast, Magda Michna discussed her role as Chief Clinical, Regulatory and Medical Affairs Officer at Staar Surgical, a position she assumed alongside Warren Foust’s appointment as COO. She stated that one of her goals was to unite previously separate clinical, regulatory, and medical affairs organizations to ensure that product registration and post-market medical information needs are aligned. Michna said she is passionate about developing the next group of leaders in these areas and emphasized that her team is responsible for the full product lifecycle, from regulatory strategy to the doctor-patient benefit-risk conversation. Michna also highlighted the company’s direct-to-consumer advertising efforts, including a campaign involving the Jonas Brothers, and noted that Staar Surgical’s EVO ICL product has achieved 99.4 percent patient satisfaction. She described the company’s growth trajectory as “explosive,” with double-digit growth in every market, and said the leadership team has aligned on core values including empowerment, fast execution, and fun. Michna added that the company customizes solutions for different customer types, from independent physicians to large private equity groups, and offers training programs to help surgeons deliver optimal outcomes.